Ranbaxy Ends Four-Year U.S. Export Hiatus With Generic Of Pfizer’s Lipitor
This article was originally published in PharmAsia News
Executive Summary
Ranbaxy Laboratories resumed exports of its generic of Pfizer’s cholesterol drug Lipitor to the U.S. in the wake of a lift of the four-year ban imposed by U.S. FDA at two of its India production facilities.